Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries

Harmony R Reynolds1, C Noel Bairey Merz2, Colin Berry3,4,5

  • 1Sarah Ross Soter Center for Women's Cardiovascular Research, Leon H. Charney Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine, New York, NY (H.R.R., N.R.S.).

Circulation Research
|February 17, 2022
PubMed

Insights

Ischemic heart disease (IHD) is a major cause of death in women. This review details sex-specific IHD risk factors and pathophysiology, focusing on ischemia with no obstructive coronary arteries in women.

Area of Science:

  • Cardiology
  • Women's Cardiovascular Health

Background:

  • Ischemic heart disease (IHD) is the primary cause of mortality in women globally.
  • Traditional cardiovascular risk factors are important, but sex-specific factors and pathophysiology contribute to IHD in women.
  • There is a need for female-specific risk stratification for IHD prevention, diagnosis, and treatment.

Purpose of the Study:

  • To review the current understanding of coronary arterial function and disease in women.
  • To focus on the mechanisms, diagnosis, and management of ischemia with no obstructive coronary arteries (INOCA) and myocardial infarction with no obstructive coronary arteries (MINOCA) in women.
  • To highlight persistent sex differences in IHD outcomes, especially in younger women.

Main Methods:

  • Review of emerging data from the past two decades on IHD in women.
  • Analysis of contemporary understanding of coronary anatomy and physiology in relation to IHD.
  • Examination of noninvasive and invasive diagnostic strategies for IHD in women.

Main Results:

  • Significant progress has been made in understanding IHD in women, including INOCA and MINOCA.
  • Sex differences in IHD outcomes persist, particularly in young women.
  • The review synthesizes current knowledge on coronary function, disease mechanisms, diagnostics, and management.

Conclusions:

  • Understanding sex-specific aspects of IHD is crucial for improving outcomes in women.
  • Further research and tailored approaches are needed for IHD prevention, diagnosis, and treatment in women.
  • Contemporary reviews are essential for addressing the complexities of IHD in women, especially concerning INOCA/MINOCA.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
216
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
72
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
54
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.7K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
154